Behrsin Rodolfo Fred, Junior Cyro Teixeira da Silva, Cardoso Gilberto Perez, Barillo Jorge Luiz, de Souza Joeber Bernardo Soares, de Araújo Elizabeth Giestal
Department of Specialist Medicine, Federal University of The State of Rio de Janeiro Brazil.
Department of Clinical Medicine, Universidade Federal Fluminense State of Rio de Janeiro, Brazil ; Pleurology Research Unit, Antonio Pedro University Hospital State of Rio de Janeiro, Brazil.
Int J Clin Exp Pathol. 2015 Jun 1;8(6):7239-46. eCollection 2015.
Closed needle pleural biopsy (CNPB) has historically been the gold standard procedure for the diagnosis of pleural tuberculosis. Adenosine deaminase (ADA) is an efficient biomarker for tuberculosis that is measurable in pleural fluids.
We compared the diagnostic accuracy of the pleural ADA (P-ADA) level and histopathological findings of CNPB specimens in patients with pleural tuberculosis.
This prospective study consisted of two groups of examinations with a proven diagnosis of pleural effusion. The P-ADA level was measured in 218 patients with pleural effusion due to a number of causes, and 157 CNPB specimens underwent histopathological analysis.
CNPBs were performed in patients with tuberculosis (n=122) and other diseases: adenocarcinoma (n=23), lymphoma (n=5), systemic lupus erythematosus (n=4), squamous cell carcinoma (n=2), and small cell lung cancer (n=1). According to the ROC curve, the optimal cut-off value of the P-ADA level (Giusti and Galanti colorimetric method) was equal to or greater than 40.0 U/L. The diagnostic accuracy of the P-ADA test was 83.0%, and that of histopathological examination of the CNPB tissue, was 78.8% (AUC=0.293, P=0.7695). The association between the P-ADA assay and pleural histopathology was 24.41 (P<0.0001). The tetrachoric correlation coefficient was 0.563 (high correlation).
In Brazil and other countries with a high incidence of tuberculosis, P-ADA activity is an accurate test for the diagnosis of tuberculous pleural effusions, and its use should be encouraged. The high diagnostic performance of the P-ADA test could to aid the diagnosis of pleural tuberculosis and render CNPB unnecessary.
闭式针吸胸膜活检(CNPB)在历史上一直是诊断胸膜结核的金标准方法。腺苷脱氨酶(ADA)是一种可在胸液中检测到的用于诊断结核病的有效生物标志物。
我们比较了胸膜结核患者胸膜ADA(P-ADA)水平与CNPB标本组织病理学检查结果的诊断准确性。
这项前瞻性研究包括两组已确诊为胸腔积液的检查。对218例因多种原因导致胸腔积液的患者测定了P-ADA水平,并对157份CNPB标本进行了组织病理学分析。
对结核病患者(n = 122)及其他疾病患者进行了CNPB,其他疾病包括腺癌(n = 23)、淋巴瘤(n = 5)、系统性红斑狼疮(n = 4)、鳞状细胞癌(n = 2)和小细胞肺癌(n = 1)。根据ROC曲线,P-ADA水平(朱斯蒂和加兰蒂比色法)的最佳截断值等于或大于40.0 U/L。P-ADA检测的诊断准确性为83.0%,CNPB组织病理学检查的诊断准确性为78.8%(AUC = 0.293,P = 0.7695)。P-ADA检测与胸膜组织病理学之间的关联度为24.41(P < 0.0001)。四分相关系数为0.563(高度相关)。
在巴西和其他结核病高发国家,P-ADA活性是诊断结核性胸腔积液的准确检测方法,应鼓励使用。P-ADA检测的高诊断性能有助于胸膜结核的诊断,使CNPB不再必要。